Literature DB >> 21127244

The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.

Arnold J Levine1, Anna M Puzio-Kuter.   

Abstract

Cells from some tumors use an altered metabolic pattern compared with that of normal differentiated adult cells in the body. Tumor cells take up much more glucose and mainly process it through aerobic glycolysis, producing large quantities of secreted lactate with a lower use of oxidative phosphorylation that would generate more adenosine triphosphate (ATP), water, and carbon dioxide. This is the Warburg effect, which provides substrates for cell growth and division and free energy (ATP) from enhanced glucose use. This metabolic switch places the emphasis on producing intermediates for cell growth and division, and it is regulated by both oncogenes and tumor suppressor genes in a number of key cancer-producing pathways. Blocking these metabolic pathways or restoring these altered pathways could lead to a new approach in cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127244     DOI: 10.1126/science.1193494

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  545 in total

1.  Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

Authors:  Anas M Abdel Rahman; Michael Ryczko; Miyako Nakano; Judy Pawling; Tania Rodrigues; Anita Johswich; Naoyuki Taniguchi; James W Dennis
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

2.  2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Martin J Walsh; Kyle R Brimacombe; Henrike Veith; James M Bougie; Thomas Daniel; William Leister; Lewis C Cantley; William J Israelsen; Matthew G Vander Heiden; Min Shen; Douglas S Auld; Craig J Thomas; Matthew B Boxer
Journal:  Bioorg Med Chem Lett       Date:  2011-09-14       Impact factor: 2.823

3.  The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Zhenghua Luo; Stefano Volinia; Laura Z Rassenti; Thomas J Kipps; Carlo M Croce
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

4.  Quantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.

Authors:  Sandra C Dos Santos; Nuno P Mira; Ana S Moreira; Isabel Sá-Correia
Journal:  OMICS       Date:  2012-07-09

5.  Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.

Authors:  Isabel Vilaseca; Ximena Terra; Francesc Xavier Avilés-Jurado; Carmen Muñoz; Carla Meler; Joan Carles Flores; Josep Gumà; Ester Benaiges; Josefina Mora; Mercedes Camacho; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-31       Impact factor: 2.503

6.  RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis.

Authors:  W Chen; Q Wang; L Bai; W Chen; X Wang; C S Tellez; S Leng; M T Padilla; T Nyunoya; S A Belinsky; Y Lin
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 7.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

8.  Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

Authors:  Jun-Ho Cho; Goo-Young Kim; Brian C Mansfield; Janice Y Chou
Journal:  Biochem Biophys Res Commun       Date:  2018-03-14       Impact factor: 3.575

9.  Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension.

Authors:  Sukrutha Chettimada; Rakhee Gupte; Dhwajbahadur Rawat; Sarah A Gebb; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-05       Impact factor: 5.464

10.  L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.

Authors:  C Rosilio; M Nebout; V Imbert; E Griessinger; Z Neffati; J Benadiba; T Hagenbeek; H Spits; J Reverso; D Ambrosetti; J-F Michiels; B Bailly-Maitre; H Endou; M F Wempe; J-F Peyron
Journal:  Leukemia       Date:  2014-12-08       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.